JBIO · Jade Biosciences, Inc.

NasdaqHealthcareBiotechnology

Jade Biosciences Inc Is A Clinical-Stage Biotechnology Company Focused On Developing Therapies For Autoimmune Diseases. Its Flagship Candidate, Jade101, Targets The Cytokine April And Is In A Phase 1 Clinical Trial For The Treatment Of Immunoglobulin A Nephropathy. The Company'S Pipeline Also Includes Jade201, An Afucosylated Anti-Baff-R Monoclonal Antibody, And Jade301, An Antibody Candidate In Preclinical Development.

HealthcareNasdaqUS

FLOAT

54.1M

FREE FLOAT %

85%

SHARES O/S

63.6M

MARKET CAP

$927.9M

EXCHANGE

Nasdaq

COUNTRY

JBIO Catalyst History

No catalysts recorded for JBIO yet

Day Trader Sniper hasn't classified a publishable catalyst for JBIO yet. New events appear here as they're scored.

Be early on the next JBIO spark.

Day Trader Sniper alerts you the instant a setup like this triggers.

How it works Download Free →

Every Second Counts.Don't Trade Without a Real-Time sparker alert.

JBIO · Jade Biosciences, Inc.

JBIO Catalyst History

Every Second Counts.
Don't Trade Without a Real-Time sparker alert.